Immunomedics (IMMU) - moderated Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU) - moderated

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

jhcimmu

rodneyh07

To: summer_sky who wrote (62971)	12/12/2024 11:56:06 AM
From: stockdoc77	2 Recommendations of 63306

Gene therapies are going for about 2-3 million dollars. They are one and done so no recurring revenue from each patient. The numbers pencil out in terms of QALY or in averted healthcare costs. If the treatment gets FDA approval the insurers cover.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next